Pyrogen Testing Market to Surpass US$ 1.9 Billion by 2026 | Thermo Fisher Scientific, Merck KGaA, Lonza Group, Associates of Cape Cod Inc

Pyrogen testing is used in detection of pyrogen contamination in pharmaceutical dosage forms and medical devices. Pyrogen contaminated injections post administration can cause temperature dysregulation (fever), bodyache, inflammation, shock, multiorgan failure, and other life threatening problems.

Moreover, increasing research and development of therapeutic drugs and medical devices is propelling growth of the pyrogen testing market over the forecast period. According to the United Nations Educational, Scientific and Cultural Organization (UNESCO), November 2016, an estimated US$ 1.7 trillion of global spending in research and development for various medical applications. Moreover, the U.S. Food and Drug Administration (FDA) and its Center for Drug Evaluation and Research (CDER), has approved around 59 novel drugs in 2018 compared to 46 approvals of new molecule entities in 2017.

Increasing launch of advanced devices by market players to augment the market growth Key players in the market are focused on development of devices for detection of pyrogen in pharmaceutical products. For instance, in March 2014, Pyrosate rapid endotoxin detection kit developed by Associates of Cape Cod, Inc., received approval from the Food and Drugs Administration (FDA) for performing endotoxin assays. Similarly, in May 2018, bioMérieux announced the launch of ENDOZYME II GO, which enables detection of endotoxin testing in pharmaceutical water grades, parenteral drugs, and other pharmaceutical products. Moreover, high investment in research & development and quality assurance by key players is expected to boost the market growth. For instance, in October 2014, new research and development center was inaugurated by bioMérieux for development of new diagnostic solutions in microbiology and increase the efficiency of laboratory procedures.

Request a sample report @ https://www.coherentmarketinsights.com/insight/request-sample/243

Key players in the market are focused on adopting strategies such as mergers and acquisitions to enhance its product portfolio. For instance, in January 2017, Merck acquired BioControl System Inc., with a strategy to penetrate in food and beverage space and strengthen its portfolio in food pathogen testing.

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide.

This release was published on openPR.